stevenpaul, Author at European Medical Journal - Page 2 of 37

Congress Wrap: ESC 2024

The European Society of Cardiology (ESC) Congress 2024, held in London, UK, was a truly groundbreaking event, bringing together the brightest…

Gilead Symposia at AIDS 2024

At the AIDS 2024 congress, Gilead Sciences hosted two interactive and engaging symposia, discussing the unmet needs and health inequities…

Unpredictability of Meningitis

Meningitis is a rare and unpredictable disease globally, with a high case fatality rate, causing an estimated 250,000 deaths in 2019…

Bridging Generations in Immune Thrombocytopenia (ITP): Adult and Pediatric Perspectives

Watch the highlights and expert interviews from the Sobi symposium ‘Bridging Generations in ITP Care: Adult and Pediatric Perspectives’…

Our new Autumn journal - out now

Is AI set to revolutionise the future of healthcare? Find out in the Autumn edition of EMJ, where we explore how AI is primed to transform…

Patient Perspectives of Navigating Life with Primary Biliary Cholangitis

Transplant hepatologist Eleonora De Martin and patient advocate Ingo van Thiel, co-host this bonus episode to support the continuing education of healthcare professionals working with primary biliary cholangitis. NX-GBL-LNR-AUDI-240001 | May 2024

Getting Ahead of Respiratory Disease Together at ERS 2024

Ahead of the European Respiratory Society (ERS) Congress 2024 in Vienna, Austria, Alberto Papi and Cedric “Jamie” Rutland share with us…

Understanding Developmental and Epileptic Encephalopathies

Developmental and epileptic encephalopathy (DEE) refers to a collection of rare and severe epilepsies that feature both seizures and…

Proliferative Lupus Nephritis with Focal Extracapillary Proliferation in Latin America

This study investigates the impact of extracapillary proliferation in proliferative lupus nephritis on remission rates in patients.

No Bolusing with Closed Loop

This article reviews real-world data presented at the ADA Scientific Sessions 2024. It demonstrates the glycaemic range when Control-IQ Technology users do not manually bolus for extended periods